drugset / Trial / NCT00742976

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

NCT00742976

Phase 4 Completed 24 enrolled Rigshospitalet, Denmark
RandomizedCrossoverOpen-labelBasic science

Summary

Hypothesis: Changing type 2 patients treatment from Insulin Insulatard to Insulin Detemir will increase their excretion of sodium in the urine and thereby decrease their extracellular volume and body weight. 24 patients are divided into 2 groups and their insulin treatment is shifted while their body composition, sodium excretion, weight and extracellular volume is monitored.

Timeline

Start
2008-06
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin NPH Protein / enzyme biologic
Comparator insulin detemir Protein / enzyme biologic